Related Experiment Video
Updated: Jun 11, 2025

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Intestinal flora and inflammatory bowel disease: Causal relationships and predictive models
Guan-Wei Bi1,2, Zhen-Guo Wu1,2, Yu Li1,2
1First Clinical College, Shandong University, Jinan, Shandong Province, PR China.
This study reveals causal links between gut bacteria and inflammatory bowel disease (IBD). Machine learning models accurately predict IBD risk, offering new therapeutic targets.
Area of Science:
- Genetics
- Microbiology
- Computational Biology
Background:
- Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is strongly influenced by the gut microbiome.
- Understanding the complex genetic and microbial interactions is vital for effective IBD prediction and treatment strategies.
Purpose of the Study:
- To elucidate the causal relationships between intestinal flora and IBD using an integrated multi-omics approach.
- To develop and validate machine learning models for predicting IBD onset and identifying potential therapeutic targets.
Main Methods:
- Employed Mendelian randomization (MR), transcriptomic analysis, and machine learning (LASSO regression, six predictive models).
- Integrated data from MiBioGen Consortium and GWAS datasets, mapping SNPs to genes and identifying differentially expressed genes (DEGs).
- Analyzed immune infiltration patterns and utilized soft voting for enhanced model reliability.
Main Results:
- Identified 25 gut microbiota classifications causally linked to IBD through MR analysis.
- Highlighted 24 significant genes and validated their causal relationship with IBD via drug target MR and colocalization.
- Revealed key pathways (PI3K-Akt, epithelial-mesenchymal transition) and distinct immune infiltration patterns.
- Demonstrated high predictive accuracy for IBD using machine learning models.
Conclusions:
- This study establishes a robust framework for predicting IBD by integrating multi-omics data and advanced computational methods.
- The findings provide novel insights into IBD pathogenesis and identify potential therapeutic targets by clarifying the gut microbiome's causal role.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

